Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
about
Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophyTargeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain.The thermo-TRP ion channel family: properties and therapeutic implications.Current and emerging "at-site" pain medications: a reviewCurrent perspectives on the modulation of thermo-TRP channels: new advances and therapeutic implications.Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade.Novel methodology to identify TRPV1 antagonists independent of capsaicin activation.Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4.Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical allodynia and thermal hyperalgesia after burn injury.Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities.
P2860
Q34619406-B1DC8C37-7F94-469D-829A-9E7A42A9E8CCQ35577699-456D5CEC-88DE-441C-8689-899E03BA9012Q37362053-7FBC2151-FB85-40C0-AA9D-B433755D3E15Q37907351-AC4719C0-80AF-4F03-81C9-50FED41A9450Q37937444-7BD262AC-3840-423C-90D6-31DACA6911EAQ37960107-442E94C3-818F-44BF-9963-61817FEABD37Q38088356-C2CA735D-73C9-4185-9A04-E7E484098AD7Q39498595-7FFE3AB5-64D7-41EA-8C3C-D24ED5C40BD7Q39565073-DAEC2CF4-A61C-4548-873F-CF998DFBE397Q39605658-F1D6943A-275D-4369-A8B6-4D9D9A562397Q47128203-DB5E64A6-6717-4F9A-A761-63C319B18632Q53351393-173641D6-1B19-4023-B14A-3A3E3C05B0AA
P2860
Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@en
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@nl
type
label
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@en
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@nl
prefLabel
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@en
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@nl
P2093
P356
P1476
Novel vanilloid receptor-1 ant ...... ction of a clinical candidate.
@en
P2093
Anthony W Bannon
Celia Dominguez
Christopher Fotsch
Elizabeth M Doherty
James Falsey
James J S Treanor
Jiawang Zhu
Jodie Katon
Liping Pettus
Mark H Norman
P304
P356
10.1021/JM070190P
P407
P577
2007-06-22T00:00:00Z